tradingkey.logo

AxoGen Inc

AXGN

17.260USD

+0.440+2.62%
終値 09/18, 16:00ET15分遅れの株価
789.91M時価総額
損失額直近12ヶ月PER

AxoGen Inc

17.260

+0.440+2.62%
詳細情報 AxoGen Inc 企業名
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its products include Avance nerve graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Axotouch Two-Point Discriminator and Axoguard HA+ Nerve Protector. Avance nerve graft is a biologically active processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site. Axoguard Nerve Connector is a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce nerve reconstruction while preventing soft tissue attachment. Axotouch Two-Point Discriminator is used to measure the innervation density of any surface area of the skin.
企業情報
企業コードAXGN
会社名AxoGen Inc
上場日Dec 17, 1986
最高経営責任者「CEO」Mr. Michael Donald (Mike) Dale
従業員数451
証券種類Ordinary Share
決算期末Dec 17
本社所在地13631 Progress Blvd.
都市ALACHUA
証券取引所NASDAQ Capital Market Consolidated
United States of America
郵便番号32615
電話番号13864626817
ウェブサイトhttps://www.axogeninc.com/
企業コードAXGN
上場日Dec 17, 1986
最高経営責任者「CEO」Mr. Michael Donald (Mike) Dale
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
151.77K
+0.91%
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
21.40K
-38.73%
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
20.76K
--
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
12.68K
-54.18%
Mr. Rick Ditto
Mr. Rick Ditto
Vice President - Global Health Economics, Reimbursement & Policy
Vice President - Global Health Economics, Reimbursement & Policy
--
--
Mr. John H. Johnson
Mr. John H. Johnson
Independent Director
Independent Director
--
--
Ms. Kathy Weiler
Ms. Kathy Weiler
Independent Director
Independent Director
--
--
Mr. Marc A. Began
Mr. Marc A. Began
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
Mr. William P. (Bill) Burke
Mr. William P. (Bill) Burke
Independent Director
Independent Director
--
--
Mr. Alan M. Levine
Mr. Alan M. Levine
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
151.77K
+0.91%
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
21.40K
-38.73%
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
20.76K
--
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
12.68K
-54.18%
Mr. Rick Ditto
Mr. Rick Ditto
Vice President - Global Health Economics, Reimbursement & Policy
Vice President - Global Health Economics, Reimbursement & Policy
--
--
Mr. John H. Johnson
Mr. John H. Johnson
Independent Director
Independent Director
--
--
収益内訳
FY2023
FY2022
データなし
地域別USD
会社名
収益
比率
United States
159.01M
0.00%
事業別
地域別
データなし
株主
更新時刻: Sat, Aug 16
更新時刻: Sat, Aug 16
株主統計
種類
株主統計
株主統計
比率
First Light Asset Management, LLC
9.84%
BlackRock Institutional Trust Company, N.A.
6.74%
The Vanguard Group, Inc.
5.92%
Morgan Stanley & Co. LLC
4.20%
Balyasny Asset Management LP
4.20%
他の
69.10%
株主統計
株主統計
比率
First Light Asset Management, LLC
9.84%
BlackRock Institutional Trust Company, N.A.
6.74%
The Vanguard Group, Inc.
5.92%
Morgan Stanley & Co. LLC
4.20%
Balyasny Asset Management LP
4.20%
他の
69.10%
種類
株主統計
比率
Investment Advisor/Hedge Fund
36.08%
Investment Advisor
26.43%
Hedge Fund
18.12%
Research Firm
5.98%
Individual Investor
4.69%
Bank and Trust
0.34%
Pension Fund
0.30%
Sovereign Wealth Fund
0.13%
Insurance Company
0.03%
他の
7.90%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
352
41.91M
91.08%
-2.35M
2025Q1
357
42.08M
92.45%
-1.70M
2024Q4
343
39.00M
87.97%
-5.62M
2024Q3
323
39.49M
90.05%
-1.54M
2024Q2
302
38.53M
87.94%
-4.16M
2024Q1
307
37.61M
87.02%
-4.05M
2023Q4
318
35.68M
82.81%
-5.15M
2023Q3
322
35.50M
82.64%
-5.39M
2023Q2
319
36.28M
84.47%
-3.01M
2023Q1
324
35.99M
84.11%
-3.05M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
First Light Asset Management, LLC
4.47M
9.82%
-32.58K
-0.72%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.13M
6.87%
+93.19K
+3.07%
Mar 31, 2025
The Vanguard Group, Inc.
2.53M
5.55%
+103.94K
+4.28%
Mar 31, 2025
Morgan Stanley & Co. LLC
1.59M
3.48%
-105.62K
-6.24%
Mar 31, 2025
Balyasny Asset Management LP
680.19K
1.49%
+380.25K
+126.77%
Mar 31, 2025
ArrowMark Colorado Holdings, LLC
1.59M
3.49%
-657.69K
-29.25%
Mar 31, 2025
Soleus Capital Management, L.P.
1.45M
3.18%
-1.51M
-51.08%
Mar 31, 2025
Wasatch Global Investors Inc
774.63K
1.7%
+774.63K
--
Mar 31, 2025
Zaderej (Karen L)
1.14M
2.51%
+71.04K
+6.62%
Mar 21, 2024
State Street Global Advisors (US)
1.01M
2.23%
+49.10K
+5.08%
Mar 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI